$ABT.US Ranked Positive On April 28th, 2026
Abbott Laboratories (ABT US, +1, 28-April-26) Philip Boudreau (Executive Vice-President – Chief Financial Officer since 2023, joined 1997) bought 11,109 shares on April 23rd at $91.93, spending $1.1 million. Boundreau has been reportable since at least 2020, and this is his first purchase, and a confident one. Prior to the purchase, he owned $6.5 million in stock and over […]
